SYSTEMIC EMBOLISM AND ANTICOAGULANT PROPHYLAXIS IN RHEUMATIC HEART DISEASE.
作者信息
SZEKELY P
出版信息
Br Med J. 1964 May 9;1(5392):1209-12. doi: 10.1136/bmj.1.5392.1209.
Abstract
摘要
相似文献
1
SYSTEMIC EMBOLISM AND ANTICOAGULANT PROPHYLAXIS IN RHEUMATIC HEART DISEASE.
Br Med J. 1964 May 9;1(5392):1209-12. doi: 10.1136/bmj.1.5392.1209.
2
MITRAL STENOSIS AND MITRAL COMMISSUROTOMY. PRE- AND POSTOPERATIVE OBSERVATIONS.
Ann Chir Gynaecol Fenn. 1964;53:289-304.
3
THERAPEUTIC EFFECT OF MITRAL COMMISSUROTOMY.
Chin Med J. 1964 May;83:300-6.
4
[ON THE INCIDENCE OF HYPERTENSION IN MITRAL STENOSIS].
Wien Z Inn Med. 1965 Mar;46:93-8.
5
ARTERIAL EMBOLISM.
Vasc Dis. 1965 Jan;2:11-3.
6
MITRAL STENOSIS AND SYSTEMIC EMBOLI.
Br Med J. 1964 Nov 7;2(5418):1169-71. doi: 10.1136/bmj.2.5418.1169.
7
[AURICULAR FIBRILLATION IN MITRAL STENOSIS].
Z Kreislaufforsch. 1963 Dec;52:1172-84.
8
SYNCHRONIZED COUNTER-SHOCK TREATMENT OF ATRIAL FIBRILLATION. A REPORT OF TWELVE CASES.
SD J Med Pharm. 1964 Jul;17:19-25.
9
CORONARY EMBOLISM IN MITRAL STENOSIS.
J Cardiovasc Surg (Torino). 1964 Sep-Oct;5:382-5.
10
[LONG-TERM ELECTROCARDIOGRAPHIC CHANGES AFTER MITRAL COMMISSUROTOMY].
Minerva Cardioangiol. 1964 Jul;12:271-6.
引用本文的文献
1
Non-Vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Atrial Fibrillation and Concomitant Mitral Stenosis: A Retrospective Observational Study.
Acta Cardiol Sin. 2025 Sep;41(5):622-633. doi: 10.6515/ACS.202509_41(5).20250429A.
2
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30.
3
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
4
Atrial fibrillation: mechanism and clinical management.
Chin Med J (Engl). 2023 Nov 20;136(22):2668-2676. doi: 10.1097/CM9.0000000000002906. Epub 2023 Nov 1.
5
Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease.
Eur Heart J Suppl. 2022 Feb 14;24(Suppl A):A19-A31. doi: 10.1093/eurheartj/suab151. eCollection 2022 Feb.
6
Long-term oral anticoagulation for atrial fibrillation in low and middle income countries.
Indian Heart J. 2021 Mar-Apr;73(2):244-248. doi: 10.1016/j.ihj.2021.02.003. Epub 2021 Feb 10.
7
Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019.
Arq Bras Cardiol. 2019 Aug 8;113(1):111-134. doi: 10.5935/abc.20190128.
8
Poor outcomes associated with antithrombotic undertreatment in patients with atrial fibrillation attending Gondar University Hospital: a retrospective cohort study.
Thromb J. 2018 Sep 18;16:22. doi: 10.1186/s12959-018-0177-1. eCollection 2018.
9
Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.
J Am Heart Assoc. 2018 Jan 26;7(3):e007338. doi: 10.1161/JAHA.117.007338.
10
A Case with Recurrent Free-Floating Ball Thrombi in Left Atrium.
Am J Case Rep. 2017 Mar 31;18:324-328. doi: 10.12659/ajcr.902633.
本文引用的文献
1
Prophylaxis of recurrent embolism of intracardiac origin; protracted anticoagulant therapy on an ambulatory basis.
J Am Med Assoc. 1950 Jul 8;143(10):870-2. doi: 10.1001/jama.1950.02910450010003.
2
Systemic arterial embolism in rheumatic heart disease.
Am Heart J. 1951 Oct;42(4):566-81. doi: 10.1016/0002-8703(51)90152-4.
3
Deterioration after mitral valvotomy.
Br Med J. 1962 Apr 14;1(5284):1027-36 contd. doi: 10.1136/bmj.1.5284.1027.
4
The course of mitral stenosis without surgery: ten- and twenty-year perspectives.
Ann Intern Med. 1960 Apr;52:741-9. doi: 10.7326/0003-4819-52-4-741.
5
The results of anticoagulant therapy in Norway.
Arch Intern Med. 1963 Feb;111:240-7. doi: 10.1001/archinte.1963.03620260100018.
6
Arterial embolization in relation to mitral valvuloplasty.
Am Heart J. 1961 Nov;62:611-20. doi: 10.1016/0002-8703(61)90369-6.
7
The risks of deferring valvotomy in patients with moderate mitral stenosis.
Lancet. 1960 Aug 13;2(7146):329-33. doi: 10.1016/s0140-6736(60)91479-3.
8
Systemic and pulmonary emboli before and after mitral commissurotomy.
Circulation. 1961 Aug;24:263-6. doi: 10.1161/01.cir.24.2.263.
9
Some clinical notes on patients with mitral valvular disease who have had mitral valvuloplasty. II.
Am Heart J. 1958 Dec;56(6):831-45. doi: 10.1016/0002-8703(58)90192-3.
10
[Arterial embolism in mitral stenosis and commissurotomy].
Arch Mal Coeur Vaiss. 1957 Feb;50(2):112-25.
Zotero 插件